Equity reseach Pila Pharma: Sizing up a small molecule in obesity
3 juni, 13:50
3 juni, 13:50
Carlsquare Equity Research has published an initial coverage report on Pila Pharma, a biotech developing a pill-based agent for e.g., metabolic diseases, and currently preparing for clinical trials in obesity.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
3 juni, 13:50
Carlsquare Equity Research has published an initial coverage report on Pila Pharma, a biotech developing a pill-based agent for e.g., metabolic diseases, and currently preparing for clinical trials in obesity.
About Carlsquare
Carlsquare is a global research firm and financial advisor, focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 150 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience about the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Contacts
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Aktieanalys
Aktieanalys
1 DAG %
Senast
OMX Stockholm 30
0,42%
(vid stängning)
Stockholmsbörsen
31 juli, 17:53
Stockholmsbörsen stänger uppåt
Apple
31 juli, 14:50
Apple faller över 7% i förhandeln
OMX Stockholm 30
1 DAG %
Senast
3 246,92